Snapshot of the Global Therapeutic Landscape of Glioblastoma Multiforme (GBM) to Deliver by Research Available at The Market Reports

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

Glioblastoma also known as glioblastoma multiforme is a fast-growing glioma that develops from star-shaped glial cells that support the health of the nerve cells within the brain. Symptoms include headaches, blurred vision, nausea, vomiting, memory loss, speech difficulty, muscle weakness and loss of appetite. Risk factors include gender (male) and age. Treatment includes surgery, radiation therapy and chemotherapy.

Report Source: https://www.themarketreports.com/report/glioblastoma-multiforme-gbm-pipeline-review-h1-2018

Scope
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Glioblastoma Multiforme (GBM) (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Glioblastoma Multiforme (GBM) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Glioblastoma Multiforme (GBM) (Oncology)

Purchase this report at: https://www.themarketreports.com/report/buy-now/1201110

List of Figures
• Number of Products under Development for Glioblastoma Multiforme (GBM), H1 2018
• Number of Products under Development by Companies, H1 2018
• Number of Products under Development by Universities/Institutes, H1 2018
• Number of Products by Top 10 Targets, H1 2018
• Number of Products by Stage and Top 10 Targets, H1 2018
• Number of Products by Top 10 Mechanism of Actions, H1 2018
• Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
• Number of Products by Top 10 Routes of Administration, H1 2018
• Number of Products by Stage and Top 10 Routes of Administration, H1 2018
• Number of Products by Top 10 Molecule Types, H1 2018
• Number of Products by Stage and Top 10 Molecule Types, H1 2018

Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1201110

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
Website: https://www.themarketreports.com/report/glioblastoma-multiforme-gbm-pipeline-review-h1-2018

Release ID: 368974